Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis ; volume:20 ; number:1 ; day:12 ; month:3 ; year:2020 ; pages:1-7 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (12.3.2020), 1-7, 12.2020
- Urheber
-
Wang, Zhe
Zhou, Da-Yan
Su, Yong
Si, Liang-Yi
Xu, Qiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-020-01403-6
- URN
-
urn:nbn:de:101:1-2020060403300093997161
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Zhe
- Zhou, Da-Yan
- Su, Yong
- Si, Liang-Yi
- Xu, Qiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
Kardiologie – Prasugrel oder Clopidogrel nach STEMI?
Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
Clopidogrel, Prasugrel und Ticagrelor beim akuten Koronarsyndrom : Rapid Report
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina
Prasugrel versus Ticagrelor nach ST-Hebungs-Myokardinfarkt: Resultate des Düsseldorfer STEMI-Registers (2009-2015)
Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
Kardiologie – Prasugrel oder Clopidogrel nach STEMI?
Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
Clopidogrel, Prasugrel und Ticagrelor beim akuten Koronarsyndrom : Rapid Report
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina
Prasugrel versus Ticagrelor nach ST-Hebungs-Myokardinfarkt: Resultate des Düsseldorfer STEMI-Registers (2009-2015)
Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
Kardiologie – Prasugrel oder Clopidogrel nach STEMI?
Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
Clopidogrel, Prasugrel und Ticagrelor beim akuten Koronarsyndrom : Rapid Report
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina
Prasugrel versus Ticagrelor nach ST-Hebungs-Myokardinfarkt: Resultate des Düsseldorfer STEMI-Registers (2009-2015)